GLP-1 Drugs Reduced Sleep Apnea Events in RCT Meta-Analysis
TL;DR: A 2026 meta-analysis in Sleep and Breathing found that GLP-1 drugs, metabolic hormone medications involved in glucose, appetite, and weight regulation, were linked to fewer obstructive sleep apnea breathing events in adults with obesity. Key Findings Sleep apnea events fell: GLP-1 treatment reduced apnea-hypopnea index (AHI), a count of breathing interruptions per hour of …
